Andolong, Eustace Noah R.
HRN: 25-25-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/07/2024
06/13/2024
IV
55mg
Q8hours
Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes